Latest Pfizer Inc News

Viatris, First Solar rise; Tyson Foods, Nvidia fall

Aug. 08, 2022 16:23 PM EDT

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday: Viatris Inc., up 36 cents to $10.09. The generic drugmaker beat Wall Street's second-quarter earnings and revenue forecasts. Tyson Foods Inc., down $7.35 to $80.10. ...

Pfizer buying spree continues with $5.4B hematology deal

Aug. 08, 2022 10:24 AM EDT

Pfizer will spend about $5.4 billion to buy Global Blood Therapeutics as the pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic. Pfizer said Monday that the acquisition will boost its work in rare hematology. Global Therapeutics,...

BioNTech reports strong first half, expects demand to grow

Aug. 08, 2022 09:08 AM EDT

BERLIN (AP) — BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year and expects demand to grow as it releases updated vaccines to target new omicron strains. The German pharmaceutical...

Growing prescriptions help push CVS past Q2 expectations

Aug. 03, 2022 10:59 AM EDT

CVS Health thumped second-quarter expectations and hiked its full-year forecast as growing prescription claims and COVID-19 test kits sales countered a drop in vaccinations. A longer cough, cold and flu season also brought in more business, and claims in CVS Health's biggest segment,...

Biden tests positive for COVID-19, returns to isolation

Jul. 30, 2022 18:45 PM EDT

WASHINGTON (AP) — President Joe Biden tested positive for COVID-19 again Saturday, slightly more than three days after he was cleared to exit coronavirus isolation, the White House said, in a rare case of “rebound” following treatment with an anti-viral drug. White House...

US rules out summer COVID boosters to focus on fall campaign

Jul. 29, 2022 16:13 PM EDT

WASHINGTON (AP) — U.S. regulators said Friday they are no longer considering authorizing a second COVID-19 booster shot for all adults under 50 this summer, focusing instead on revamped vaccines for the fall that will target the newest viral subvariants. Pfizer and Moderna expect...

Pfizer's Comirnaty, Paxlovid push Q2 sales to new heights

Jul. 28, 2022 09:42 AM EDT

Sales of Pfizer’s COVID-19 vaccine and treatment in the second quarter propelled the pharmaceutical giant to the largest quarterly sales in its history. The coronavirus vaccine Comirnaty brought in $8.85 billion in sales, and the treatment Paxlovid added another $8.12 billion as...

Merck beats expectations, helped by Keytruda sales

Jul. 28, 2022 07:13 AM EDT

Merck's second-quarter sales and profit easily beat Wall Street expectations Thursday, boosted by sales growth of some of its key drugs. Merck & Co. posted profit of $3.94 billion, or $1.87 per adjusted share, easily beating the $1.70 that analysts surveyed by data firm FactSet...

Biden tests positive for COVID-19, has 'very mild symptoms'

Jul. 22, 2022 07:54 AM EDT

WASHINGTON (AP) — President Joe Biden tested positive for COVID-19 on Thursday and went into isolation with mild symptoms. White House officials went all-out to show that the 79-year-old U.S. leader could power through the virus and keep working because he was vaccinated and boosted. ...

Biden tests positive for COVID-19, has 'very mild symptoms'

Jul. 21, 2022 13:08 PM EDT

WASHINGTON (AP) — President Joe Biden tested positive for COVID-19 on Thursday and is experiencing “very mild symptoms,” the White House said, as new variants of the highly contagious virus are challenging the nation's efforts to get back to normal after two and a half years of pandemic...